WeedWeek edition
/ February 08, 2022
A new ripple in the MedMen / Ascend suit
WeedWeek edition
02/03/22
How to save cannabis equity
WeedWeek edition
01/31/22
Three cannabiz court cases to watch
WeedWeek edition
01/28/22
Amazon endorses GOP legalization bill
WeedWeek edition
01/25/22
MedMen countersues Ascend over broken N.Y. deal
WeedWeek edition
01/20/22
MedMen founder Bierman tells his story
WeedWeek edition
01/17/22
Ascend sues MedMen over broken N.Y. deal
WeedWeek edition
01/13/22
California biz rallies in Sacramento
WeedWeek edition
01/11/22
Budweiser-maker and Tilray break up
WeedWeek edition
01/07/22
MedMen / Ascend dispute escalates
WeedWeek edition
01/04/22
MedMen terminates N.Y. deal with Ascend
WeedWeek edition
12/27/21
WeedWeek’s cannabiz predictions for 2022
WeedWeek edition
12/21/21
Ten biggest weed stories of 2021
WeedWeek edition
12/17/21
Market collapse “imminent,” California biz warns
WeedWeek edition
12/13/21
How MSOs evaluate brands
WeedWeek edition
12/10/21
Five takeaways from Hall of Flowers
WeedWeek edition
12/07/21
Jushi thinks corporate weed can be cool
WeedWeek edition
12/03/21
SuperNet: A credit card for dispensaries
WeedWeek edition
11/29/21
Harborside to acquire Urbn Leaf and Loudpack
WeedWeek edition
11/23/21
Uber Eats to support weed pickup orders
WeedWeek edition
11/18/21
Berner and Weedmaps’ social venture is legit
WeedWeek edition
11/15/21
LeafLink reveals top brands of 2021
WeedWeek edition
11/08/21
MSOs’ growth plan leaked
WeedWeek edition
11/04/21
Former MedMen execs give “damning testimony” in court
WeedWeek edition
11/01/21
New York: No licenses before 2023